Claritev Corporation (CTEV)
NYSE:CTEV
Want to see CTEV full AI Analyst Report?
Earnings Data
Report Date
Jul 30, 2026Before Open (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
-3.85Last Year’s EPS
-3.81Same Quarter Last Year
Strong Buy
Based on 5 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call conveyed a predominantly positive operational and financial trajectory: revenue and adjusted EBITDA outperformed expectations, ACV bookings and pipeline showed strong momentum (+70% pipeline growth, $44.1M ACV in Q1), and AI-driven efficiencies are producing measurable productivity gains. Management is investing to expand services and enter new verticals (public sector, large health systems) while maintaining full-year EBITDA guidance and raising the bottom end of revenue guidance. Near-term headwinds include modest PSAV volume declines, the expected cash-consumption pattern in Q1/Q3 due to working capital and interest normalization, and lower-margin services during ramp; however, these were presented as deliberate, invest-to-scale initiatives with visibility into ACV conversion and revenue ramping in 6–12 months.Company Guidance
Revenue and EBITDA Outperformance
Total revenue of $244.7M in Q1, up 5.8% year-over-year; adjusted EBITDA of $146.9M, up 3.4% year-over-year, representing a 60% EBITDA margin. Management raised the bottom end of full-year revenue guide to $985M–$1.0B and maintained full-year adjusted EBITDA guidance of $605M–$615M (61%–62% margins).
Strong ACV Bookings and Sales Momentum
Q1 ACV bookings of $44.1M toward a $80M–$100M 2026 ACV target (20%–50% growth vs. last year). Pipeline growth +70% year-over-year; closed 19 deals >$100K ACV and 9 deals >$1M ACV (350% increase in 7-figure deals). Average deal size more than doubled, with 73% of bookings from cross-sell/upsell and 27% from net-new clients; pipeline coverage improved to ~4.8x.
Material Cash Flow Improvement
Generated $36.8M of unlevered free cash flow in Q1, up 181% year-over-year (+$23.7M). Company reiterates positive free cash flow for the year and capital spending guidance of $160M–$170M.
Core Product Strength and Mix Benefits
Claims intelligence flagship (Data iSight) contributed to growth, with that service line up 8.4% in the quarter. Network and payment integrity lines performed at or slightly above expectations. Management notes PSAV modest volume declines were more than offset by favorable rate/mix and higher-acuity claims driving savings per claim.
Strategic Customer Wins and Market Expansion
Signed agreement with GDIT to provide a custom network for the World Trade Center Health Program (entry into public sector) and closed a contract with a top-5 health system (operator of >700 facilities). The top-5 health system win was enabled by the Q4 acquisition of OPCG, supporting the newly launched services offering.
AI-Driven Operational Efficiency and Automation Wins
AI/code tools nearly doubled engineering coding capacity without headcount increase. Built a provider contact agent that reduces process time by >50% and saved >2,000 hours. Automated invoice extraction/reconciliation to handle thousands of invoices daily with nearly 100% accuracy, freeing resources and reducing costs.
Improving Visibility into Future Revenue
Management expects ACV conversion to revenue in ~6–12 months; Q1 pipeline provides visibility to hit bookings and revenue targets. Forecasts sequentially flat Q2, and 3%–5% growth in the second half as new ACV ramps into revenue, supporting the full-year guide.
CTEV Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
CTEV Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 07, 2026 | $26.47 | $24.21 | -8.54% |
Feb 23, 2026 | $23.23 | $13.57 | -41.58% |
Nov 07, 2025 | $61.96 | $69.25 | +11.77% |
Aug 06, 2025 | $39.52 | $51.14 | +29.40% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Claritev Corporation (CTEV) report earnings?
Claritev Corporation (CTEV) is schdueled to report earning on Jul 30, 2026, Before Open (Confirmed).
What is Claritev Corporation (CTEV) earnings time?
Claritev Corporation (CTEV) earnings time is at Jul 30, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CTEV EPS forecast?
CTEV EPS forecast for the fiscal quarter 2026 (Q2) is -3.85.